Ardsley Advisory Partners’s Pediatrix Medical MD Stock Holding History

Ardsley Advisory Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,000	Closed	-$363K	–	204
2015 Q1	$363K	Hold	5,000	–	–	0.05%	141
2014 Q4	$331K	Hold	5,000	–	–	0.05%	149
2014 Q3	$274K	Hold	5,000	–	–	0.04%	154
2014 Q2	$291K	Buy	+5,000	New	+$294K	0.04%	205

Other funds holding MD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Ardsley Advisory Partners's MD Position: Q2 2015 in Review

Ardsley Advisory Partners sold out of Pediatrix Medical (MD) in Q2 2015, closing a stake of 5,000 shares — an estimated $363K sold.

Ardsley Advisory Partners first reported a position in MD in Q2 2014 and held it in 4 quarters. The position peaked at $363K in Q1 2015. 355 funds tracked by Wall St. Rank hold MD as of Q2 2015.

Ardsley Advisory Partners reported no remaining Pediatrix Medical position as of Q2 2015 after selling out during the quarter.
Ardsley Advisory Partners sold 5,000 Pediatrix Medical shares in Q2 2015, an estimated $363K.
Ardsley Advisory Partners first reported a position in Pediatrix Medical in Q2 2014 and held it in 4 quarters.
Ardsley Advisory Partners's Pediatrix Medical position peaked at $363K in Q1 2015.
355 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2015.

Based on Ardsley Advisory Partners's 13F filing for Q2 2015, filed 14 Aug 2015.